Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-018772
Filing Date
2021-03-08
Accepted
2021-03-08 19:48:46
Documents
1
Period of Report
2021-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4323
  Complete submission text file 0001209191-21-018772.txt   5708
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address
Longpre Lara (Reporting) CIK: 0001780347 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38981 | Film No.: 21723648